Yes, pregabalin 50 mg twice daily (100 mg/day total) can cause drowsiness, though this dose is below the typical therapeutic range and may have a lower incidence of sedation compared to higher doses.
Evidence from FDA Drug Labeling
The FDA label explicitly warns that pregabalin causes somnolence (drowsiness) as one of its most common adverse effects 1. In controlled trials of adult patients:
- 23% of pregabalin-treated patients experienced somnolence compared to only 8% of placebo-treated patients
- Somnolence was dose-dependent, occurring more frequently at higher doses
- Somnolence typically began shortly after initiating therapy
- In patients who reported somnolence, 42% continued experiencing it until their last dose
- Somnolence was one of the two most frequent reasons for treatment discontinuation (4% withdrawal rate)
Dose-Specific Considerations
Your specific dose of 50 mg twice daily (100 mg/day total) is at the very low end of the dosing spectrum:
- Standard therapeutic dosing ranges from 150-600 mg/day in divided doses 2
- Guidelines recommend starting at 25-50 mg/day in older adults or those at higher risk 3
- The typical starting dose is 50 mg three times daily or 75 mg twice daily (150 mg/day total) 2
At 100 mg/day, you are below the usual therapeutic threshold, which means:
- The risk of drowsiness exists but may be lower than at therapeutic doses
- The dose-dependent nature of sedation suggests reduced incidence at this lower dose
- However, individual sensitivity varies considerably
Clinical Context and Risk Factors
Drowsiness risk is amplified by several factors 3, 1:
- Co-administration with CNS depressants (opioids, benzodiazepines, alcohol) significantly increases sedation and respiratory depression risk
- Renal impairment requires dose reduction and increases side effect risk
- Older adults are particularly vulnerable to somnolence, dizziness, and mental clouding 3
- Rapid titration increases the likelihood of sedation
Practical Management
If you experience drowsiness on this dose:
- Tolerance often develops within a few weeks 4 - the sedation may diminish with continued use
- Timing matters: Taking the full dose at bedtime rather than splitting it may reduce daytime drowsiness
- Avoid driving or operating machinery until you know how the medication affects you 1
- Do not combine with alcohol or other sedating medications without medical supervision
- Gradual dose escalation from even lower starting doses (25 mg/day) may improve tolerability 3
Common Pitfalls to Avoid
- Don't assume the low dose eliminates risk - individual responses vary widely, and some patients experience sedation even at sub-therapeutic doses
- Don't abruptly discontinue if drowsiness is intolerable - taper over at least one week to avoid withdrawal symptoms 1
- Don't ignore persistent severe drowsiness - this may indicate the need for dose adjustment or medication change
- Don't overlook drug interactions - review all concurrent medications, particularly CNS depressants
The evidence clearly establishes that drowsiness is a common, dose-dependent side effect of pregabalin at all doses, though your 100 mg/day dose carries lower risk than standard therapeutic doses of 150-600 mg/day 3, 2, 1.